High satisfaction with fluticasone propionate/salmeterol via diskus reported during experience program in patients with COPD

被引：0
|
作者：
Stoloff, S [1 ]
Samuels, S [1 ]
Braman, S [1 ]
Brown, C [1 ]
Kerney, D [1 ]
Cicale, M [1 ]
机构：
[1] Univ Nevada, Sch Med, Reno, NV 89557 USA
来源：
CHEST | 2005年 / 128卷 / 04期
关键词：
D O I：
10.1378/chest.128.4_MeetingAbstracts.260S-b
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：260S / 260S
页数：1
相关论文
共 50 条
  • [41] Impact of adherence to treatment with tiotropium co-administered with fluticasone propionate/salmeterol combination in COPD patients
    Lsmaila, Afisi
    Sampalis, John
    Corriveau, Diane
    Vaillancourt, Julie
    Parsons, Dana
    Dalal, Anand
    Su, Zhen
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [42] Symptom Burden in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy
    Moretz, C.
    Hahn, B.
    White, J.
    Hunter, A. Goolsby
    Essoi, B.
    Elliott, C.
    Ray, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [43] Fluticasone propionate/salmeterol administered via Diskus® provides protection against activity-induced bronchospasm in children and adolescents with persistent asthma.
    Stauffer, J.
    Watikus-Edwards, K.
    Yancey, S.
    Emmett, A.
    Sutton, L. B.
    Dorinsky, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 98 (01) : A62 - A62
  • [44] Treatment of Asthmatic Patients with Fluticasone Propionate and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhalers Compared with Placebo: Patient-Reported Outcomes and Quality of Life
    Sher, Lawrence
    Yiu, Gloria
    Sakov, Anat
    Liu, Siyu
    Caracta, Cynthia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB97 - AB97
  • [45] The Towards a Revolution in COPD Health (TORCH) study: Fluticasone propionate/salmeterol is well tolerated in patients with COPD over 3 years
    Ferguson, Gary T.
    Calverley, Peter M.
    Anderson, Julie A.
    Celli, Bartolome
    Jenkins, Christine
    Jones, Paul W.
    Vestbo, Jorgen
    Yates, Julie C.
    Pride, Neil
    CHEST, 2006, 130 (04) : 178S - 178S
  • [46] The effect of tiotropium/olodaterol versus fluticasone propionate/salmeterol on left ventricular filling and lung hyperinflation in patients with COPD
    Herth, Felix
    Hohlfeld, Jens M.
    Haas, Johannes
    de la Hoz, Alberto
    Jin, Xidong
    Kreitner, Karl-Friedrich
    Vogelmeier, Claus
    Vogel-Claussen, Jens
    Watz, Henrik
    BMJ OPEN RESPIRATORY RESEARCH, 2020, 7 (01)
  • [47] Impact of Smoking Status on Improvements in Lung Function with Umeclidinium/Vilanterol Vs Fluticasone Propionate/Salmeterol in Patients with COPD
    Asmus, M. J.
    Tombs, L.
    Ray, R.
    Naya, I.
    Boucot, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [48] Patient-Reported Outcomes and Quality of Life Improved with Fluticasone Propionate and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhalers Versus Placebo in Patients with Persistent Asthma
    Raphael, Gordon
    Yiu, Gloria
    Sakov, Anat
    Liu, Siyu
    Caracta, Cynthia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB10 - AB10
  • [49] Efficacy of Fluticasone propionat/salmeterol combination compared to fluticasone propionate alone in patients allergic to house dust mite (our experience)
    Breskovska, G.
    Stevceska, G.
    Stojkovic, J.
    Kaeva, B.
    ALLERGY, 2007, 62 : 212 - 212
  • [50] Pharmacokinetics of Fluticasone Propionate Inhaled via the Diskhaler® and Diskus® Powder Devices in Patients with Mild-to-Moderate Asthma
    Christine Falcoz
    John Horton
    Alison E. Mackie
    Stuart M. Harding
    Peter T. Daley-Yates
    Clinical Pharmacokinetics, 2000, 39 : 31 - 37
12345